PMC:7195088 / 18001-18280
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 662 | 144-152 | Species | denotes | patients | Tax:9606 |
| 758 | 14-33 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 759 | 67-86 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 760 | 121-130 | Chemical | denotes | xiyanping | |
| 923 | 158-166 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T89 | 158-166 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T93 | 173-178 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T143 | 14-33 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T144 | 14-23 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T145 | 24-33 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T146 | 47-57 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T147 | 67-86 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T148 | 67-76 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T149 | 77-86 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T150 | 100-110 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T151 | 173-178 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T121 | 168-217 | Sentence | denotes | Open-label RCT (NCT04275388, not yet recruiting). |
| T122 | 218-279 | Sentence | denotes | Primary endpoint: clinical recovery time (follow-up 14 days). |